Boursa Kuwait has recently reported noteworthy developments in its financial landscape, particularly in the first quarter of the year. Despite a slight
Mirum Pharmaceuticals has reported a robust performance in the second quarter of 2025, marked by significant growth in product revenues driven primarily
In a bold move to enhance its portfolio in nephrology, Biogen has acquired Apellis Pharmaceuticals for $5.6 billion. This strategic acquisition not only
The Indian Space Research Organisation (ISRO) and the All India Institute of Medical Sciences (AIIMS) have recently entered a significant memorandum of
Japan has taken a monumental step in the field of regenerative medicine by conditionally approving the commercialization of two groundbreaking stem cell